Poland – Pharmaceutical products – Successive deliveries of medicinal products, including medicinal products used in drug programs, dialysis solutions, and parenteral nutrition products to the Hospital Pharmacy of the Healthcare Complex in Bolesławiec
The subject of the contract is the successive delivery of medicinal products, including medicinal products used in drug programs, dialysis solutions, and parenteral nutrition products to the Hospital Pharmacy of the Healthcare Complex
Opportunity description
The subject of the contract is the successive delivery of medicinal products, including medicinal products used in drug programs, dialysis solutions, and parenteral nutrition products to the Hospital Pharmacy of the Healthcare Complex in Bolesławiec. A detailed description of the subject of the contract is contained in the Price Form – Annexes Nos. 2.1–2.15 to the SWZ. Each Contractor may submit only one tender for the entire contract or for a given task/tasks in writing, otherwise it shall be null and void. If a Contractor submits more than one tender for the entire contract or for a given task/tasks, all tenders submitted by that Contractor shall be rejected by the Contracting Authority. The contract consists of 15 tasks. The Contracting Authority permits the submission of partial tenders. The Contracting Authority shall consider a tender submitted for all items in a given task to be a partial tender. The Contracting Authority does not permit the submission of tenders for individual items. The Contracting Authority stipulates that the offered subject of the contract must belong to the group of medicinal products in accordance with Article 2(32) and Article 2(40) of the Pharmaceutical Law Act of 6 September 2001 (consolidated text: Journal of Laws of 2023, item 1938). The offered products must have the appropriate certificates or approvals permitting their use in healthcare in accordance with Polish law and European Union law. Medicinal products (medicines) must be entered in the Official Register of Medicinal Products Authorized for Marketing in the territory of the Republic of Poland. Tenofovir Entecavir Lamivudine Glecaprevir/pibrentasvir Botulinum toxin I Botulinum toxin II Botulinum toxin III Dialysates I Dialysates II Various medicines I Various medicines II Inhalation anesthetics together with the lease of vaporizers Albumins Intravenous medicines Nutrition Procedure: open. Estimated value: 5,708,781.7 PLN. Review the original TED notice for the complete requirement, lots, amendments and attachments.
Business details are available after sign in
Codes, capabilities, evidence, buyer details and marketplace actions are withheld from the public HTML and API response.